MedTrace Logo

Submandibular Gland Stem Cell Transplantation

NCT04593589 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-10-22

No results posted yet for this study

Summary

This study is a phase I safety and feasibility study to treat head and neck cancer patients with autologous salivary gland stem cell transplantation after postoperative (chemo)radiotherapy.

Conditions

Interventions

OTHER

Submandibular Gland Stem Cell Transplantation

Autologous transplantation of salivary stem cells (salisphere derived cells) cultured in vitro as obtained from submandibular glands after postoperative radiotherapy

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • R.J.H.M. Steenbakkers, MD, PhD · UMC Groningen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2026-01-01
Completion
2029-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593589 on ClinicalTrials.gov